Close
What would you like to look for?
Site search

75 results:

BKW Netzbeteiligung AG acquires 30.3% of Swissgrid shares from Alpiq

… Suisse Anlagestiftung. The team led by partner Dr. Stefan Rechsteiner (Regulatory) included partners Dr. Felix…

Newly launched Vicarius Pharma secures CHF21 million financing

… W. Egli (Partner, Corporate), team leader, and Stefan Kohler (Partner, Regulatory Life Science), Roland…

evitria Group sold to Atlas Antibodies, Sweden

… Dr. Adrian Dörig (Partner, Banking/Finance), Dr. Stefan Kohler (Partner, IP/Regulatory), Christian Schneiter…

MCAM Symalit acquires Recycling Activities from Minger Kunststofftechnik

… W. Egli (Partner, Corporate/M&A) included Stefan Kohler (Partner, IP), Christoph Niederer (Partner,…

Limited Qualified Investor Fund ("L-QIF")

Limited Qualified Investor Fund ("L-QIF")

… further questions you may have. Author: Stefan Grieder

SHS invests in Simulands AG

… (Partner, Corporate/M&A) and included Dr. Stefan Kohler (Partner, IP/Regulatory), Elias Mühlemann…

Numab and Sunshine Guojian form partnership

… acted as counsel to Numab. The team was led by Stefan Kohler (IP/Life Sciences) and Christian Wyss…

Client Segmentation under FinSA

Client Segmentation under FinSA

… was planned). Authors: Jana Essebier, Stefan Grieder

NUMAB concludes Licensing and Development Agreement in China

… in this transaction. The VISCHER team is led by Stefan Kohler (Partner, Life Sciences & IP) and…

CombiGene and Spark enter global licensing agreement for gene therapy

… double-digits based on net sales. VISCHER (Dr. Stefan Kohler) advised CombiGene in the negotiations of the…